Search Results
Results found for "yA TZU LI"
- Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its...
transient cAMP production, acute intracellular Ca2+ (iCa2+) release and β-arrestin recruitment mediated by ligand-PTHR
- Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells...
As therapeutic options are limited, novel targets and agents for therapeutic intervention are urgently
- Fentanyl activates ovarian cancer and alleviates chemotherapy-induced toxicity via opioid...
Although increasing evidence has suggested the direct role of fentanyl on cancer, little is known on
- Chemerin Forms: Their Generation and Activity
Chemerin is produced by the liver and secreted into the circulation as a precursor, but it is also expressed
- PI(4,5)P 2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-c
Using purified Fzd proteins reconstituted in lipid nanodiscs, we investigated the factors that promote We found that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR superfamily for which the binding of extracellular ligands affects the affinity for downstream Instead, Fzd-Dvl binding was enhanced by increased concentration of the lipid PI(4,5)P2, which is generated by Dvl-associated lipid kinases in response to Wnt and which is required for LRP5/6 phosphorylation.
- CCL25/CCR9 interaction promotes the malignant behavior of salivary adenoid cystic carcinoma via...
CC chemokine receptor 9 (CCR9), an organ-specific chemokine receptor, interacts with its exclusive ligand
- G protein coupling and activation of the metabotropic GABAB heterodimer
However, little is known about the mechanism for GP coupling and activation for class C GPCRs.
- GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
We identified a novel GRK3 inhibitor, LD2, through a chemical-library screen.
- Neurotransmitters: Potential Targets in Glioblastoma
Significantly, many ligands acting on neurotransmitter receptors have shown great potential for inhibiting
- GPCR/endocytosis/ERK signaling/S2R is involved in the regulation of the internalization...
We also adopted live cell imaging to monitor the whole intracellular trafficking process of F-Hst1.
- Platelets in the NETworks interweaving inflammation and thrombosis
In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than
- Structure of Mycobacterium tuberculosis Cya, an evolutionary ancestor of the mammalian membrane...
domain and providing the means for direct regulation of catalytic activity in response to extracellular ligands
- Trainees, this is for you...
Would you like to develop your presentation skills? Give a talk or present a poster at the Dr.
- Carola Weiss joins InterAx Biotech AG as VP Business Development
Carola Weiss’ professional career brings deep expertise in business development, marketing & sales, licensing
- Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline ...
England & BOSTON--Sanofi and Exscientia announced today a groundbreaking research collaboration and license The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia’s novel
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
DIEGO, Dec. 7, 2021 /PRNewswire/ -- Neurocrine Biosciences (Nasdaq: NBIX) today announced positive top-line
- ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated ...
receive marketing authorization in all member states of the European Union, as well as in Iceland, Liechtenstein
- 4GPCRnet, September 26-29, 2022. Leipzig, Germany
will take place in the heart of Leipzig, which offers a colorful mixture of culture and vivid social life
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
It is a therapeutic target because it plays a role in thermogenesis, lipolysis, and bladder relaxation Ligand-based pharmacophore modeling was performed since no 3D structure of human β3 -AR is yet available
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
Erythrocytes are terminally differentiated anuclear cells with no transcription and limited translation Accordingly, within the erythroid lineage ACKR1 expression occurs first and is the highest in erythroblasts venular endothelial cells (ECs) ( Pruenster et al., 2009 ; Thiriot et al., 2017 ), including those lining macrophages, but not erythroblasts and ECs, suggesting that macrophage ACKR1 engages its non-cognate ligand In light of the extensive literature, these findings have been particularly provocative, as this was
- 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy
Wednesday-Friday, 5th-7th October 2022 Place Evotec Campus Levi-Montalcini, Verona, Italy Downloads and Links
- Anatomy of a partnership: Cancer Research UK teams up with Sosei Heptares
Cancer Research UK, a charity dedicated to funding lifesaving oncology research, spent £388 million on
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living
- Crinetics Presents Clinical And Research Results At ENDO 2022
serum cortisol levels and 24-hour urine free cortisol excretion in the presence of sustained, disease-like
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
discovery involving the gut-brain axis, will gain unique and valuable access to the Sosei Heptares compound library
- Targeting the M1 muscarinic receptor in neurodegenerative disease
cognitive and neurodegenerative disorders and the potential therapeutic benefit of muscarinic M1 selective ligands
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
Vraniak’s career spans more than 20 years of financial and commercial experience in the life sciences
- Domain Therapeutics Raises $42m Series A Financing
announced today the closing of a US $42m (€39m) series A financing round co-led by Panacea Venture, CTI Life
- Design Pharmaceuticals Closes $5 Million Pre-series A Round to Accelerate Commercialization of ...
Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
structure-based drug design platform and enhancing translational medicine capabilities • ‘Venture-like value generation • Mid-term global expansion plans include drug discovery technology investments, licensing

